Close
4

Seqens Seqens

X

Company profile for Palatin Technologies

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Palatin Technologies, Inc. (NYSE American: PTN) is a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Our product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Vyleesi™, the trade name for Br...
Palatin Technologies, Inc. (NYSE American: PTN) is a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Our product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Vyleesi™, the trade name for Bremelanotide, for the treatment of hypoactive sexual desire disorder (HSDD) is our lead product. A New Drug Application for approval of Vyleesi was approved by the Food and Drug Administration (FDA) in June 2019.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Palatin Technologies
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
4-B Cedar Brook Drive Cedar Brook Corporate Center Cranbury, NJ 08512
Telephone
Telephone
1-609-495-2200
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY